Not Yet RecruitingNot Applicable

Analysis of Motor Performance in Children with Duchene's Muscular Dystrophy

25 participantsStarted 2024-12-27

Plain-language summary

25 boys, ages ranging from 6 to 16 years, diagnosed with Duchene's muscular Dystrophy (DMD) will participated in the study. They will be selected from the Pediatric Rehabilitation Center of Deraya University's outpatient clinic in El-Minia district, Minia-Egypt. The outcome will be assessed motor performance will be assed by Bruininks-Oseretsky Test of Motor Proficiency Second Edition (BOT™-2) : balance, running speed and agility, bilateral coordination and strength and by Blue Cherry; Geratherm Respiratory. It is used to measure vital capacity (VC), forced expired volume in one second (FEV1), FEV1/FVC, FEV1/VC, and peak expiratory flow (PEF) to provide objective information for monitoring lung health.

Who can participate

Age range6 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * the diagnosis is Duchene's muscular Dystrophy only not other types, * ambulated with or without assistance, * oriented and endurance enough to understand orders to perform ventilation on the Blue Cherry; Geratherm Respiratory device. Exclusion Criteria: * any cognitive or neurological condition (other than Duchene's muscular Dystrophy), * history of previous surgical operations that can affect pulmonary functions, and structural scoliosis

What they're measuring

motor performance

Timeframe: measured for one time

respiratory function

Timeframe: measured for only one time

Trial details

NCT IDNCT06750042

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-30

Contact for this trial

Ahmed Salman

+962797168340 a.salman@ammanu.edu.jo

View on ClinicalTrials.gov More Duchene's Muscular Dystrophy trials